⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ECOR News
electroCore, Inc. Common Stock
electroCore to Announce Third Quarter September 30, 2026, Financial Results on Wednesday, November 4, 2026
globenewswire.com
ECOR
electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)
globenewswire.com
ECOR
fMRI Study Suggests Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) Accelerates Neural Processes in Visual Skill Learning
globenewswire.com
ECOR
electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub
globenewswire.com
ECOR
Nerve Repair and Regeneration Market worth $12.64 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
BSX
AXGN
MDT
ABT
BIIB
GNRC
ECOR
electroCore to Participate at H.C. Wainwright Global Investment Conference
globenewswire.com
ECOR
Form 8-K
sec.gov
ECOR
electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers
globenewswire.com
ECOR
Bioelectronic Medicine - Market Insights, Competitive Landscape, and Market Forecast - 2034 Now Available — Global Market Analysis, Key Players, Product Segments, and Emerging Technologies
globenewswire.com
MDT
BSX
ABT
LIVN
INSP
ECOR
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards
globenewswire.com
ECOR